Browse by author
Lookup NU author(s): Stewart Barclay, Dr Nick Steen, Professor Philip Preshaw
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
This study assessed the efficacy of the Bioxtra (BX) and Biotène Oralbalance (OB) systems in the treatment of post-radiotherapy xerostomia. In a double-blind, crossover study, 20 patients with post-radiotherapy xerostomia were randomly allocated to receive either OB then BX, or vice versa, each product for 2 weeks, with a 1 week wash-out period in between. Subject-based dry mouth scores derived from 100-mm visual analogue scales were recorded at days 0 and 14 of each 2-week period, together with subjective perception of changes in dry mouth symptoms. Both treatments were effective, resulting in reduction of visual analogue scale scores from day 0-14. Between-groups comparisons identified that BX achieved significantly better improvements compared with OB for the perception of dry mouth and improvements in speech and was also rated as more pleasant to use than OB (P < 0.05). In conclusion, both treatments were effective in alleviating the symptoms of post-radiotherapy xerostomia, although BX achieved superiority in some of the outcomes assessed compared with OB. © 2005 Blackwell Publishing Ltd.
Author(s): Shahdad SA, Taylor C, Barclay SC, Steen IN, Preshaw PM
Publication type: Article
Publication status: Published
Journal: European Journal of Cancer Care
Year: 2005
Volume: 14
Issue: 4
Pages: 319-326
Print publication date: 01/09/2005
ISSN (print): 0961-5423
ISSN (electronic): 1365-2354
Publisher: Wiley
URL: .http:/dx.doi.org/10.1111/j.1365-2354.2005.00587.x
DOI: 10.1111/j.1365-2354.2005.00587.x
PubMed id: 16098116
Altmetrics provided by Altmetric
